As of Feb 22
| -1.07 / -0.77%|
The 12 analysts offering 12-month price forecasts for BeiGene Ltd have a median target of 200.00, with a high estimate of 215.00 and a low estimate of 148.90. The median estimate represents a +45.16% increase from the last price of 137.78.
The current consensus among 13 polled investment analysts is to Buy stock in BeiGene Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.